Who is sponsoring NCT03874949?

NCT03874949 is sponsored by ACTEON Group.

What condition does NCT03874949 study?

NCT03874949 studies Root Canal Obturation.

What drugs are being tested in NCT03874949?

Interventions: SEALITE Regular, SEALITE Ultra.

What is the status of NCT03874949?

NCT03874949 is currently COMPLETED.

Last reviewed 2019-09-04 · How we verify

Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone

NCT03874949 NA COMPLETED

This study aims to assess the efficacy of a zinc oxide eugenol sealer containing Enoxolone, a non-steroidal anti inflammatory drug (NSAID) on the pain relief after endodontic treatment. The study design is a multicenter, doubled blinded randomized controlled trial. The comparator is the equivalent zinc oxide eugenol sealer without NSAID (allocation ratio is 1:1). The conventional endodontic treatment, using gutta percha and sealer, is done. Patients assess their pain for 7 days after permanent root obturation.

Details

Lead sponsor	ACTEON Group
Phase	NA
Status	COMPLETED
Enrolment	95
Start date	Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Root Canal Obturation

Interventions

SEALITE Regular
SEALITE Ultra

Countries

France